Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
Emergent BioSolutions (NYSE: EBS) has scheduled its first quarter 2025 financial results conference call for May 7, 2025, at 5:00 pm eastern time. The company will provide investors and stakeholders access to the conference call through multiple channels:
- Live webcast access
- Telephone participation (requires advance registration)
- Replay availability on the company's Investors webpage
Registered telephone participants will receive confirmation emails with dial-in details, including a unique passcode and registrant ID for call access.
Emergent BioSolutions (NYSE: EBS) ha programmato la conference call per i risultati finanziari del primo trimestre 2025 per il 7 maggio 2025 alle 17:00 ora della costa orientale. L'azienda offrirà agli investitori e agli stakeholder l'accesso alla conference call tramite diversi canali:
- Accesso alla diretta web
- Partecipazione telefonica (richiede registrazione anticipata)
- Disponibilità della registrazione sulla pagina Investitori del sito aziendale
I partecipanti telefonici registrati riceveranno un'email di conferma con i dettagli per la chiamata, inclusi un codice d'accesso unico e un ID registrazione per l'accesso alla chiamata.
Emergent BioSolutions (NYSE: EBS) ha programado su llamada de conferencia para los resultados financieros del primer trimestre de 2025 para el 7 de mayo de 2025 a las 5:00 pm hora del este. La compañía ofrecerá a inversores y partes interesadas acceso a la llamada de conferencia a través de varios canales:
- Acceso a la transmisión en vivo
- Participación telefónica (requiere registro previo)
- Disponibilidad de la grabación en la página de inversores de la compañía
Los participantes telefónicos registrados recibirán un correo de confirmación con los detalles para marcar, incluyendo un código de acceso único y un ID de registro para acceder a la llamada.
Emergent BioSolutions (NYSE: EBS)는 2025년 1분기 재무 실적 컨퍼런스 콜을 2025년 5월 7일 오후 5시(동부 표준시)에 예정했습니다. 회사는 투자자와 이해관계자들이 여러 채널을 통해 컨퍼런스 콜에 참여할 수 있도록 제공합니다:
- 라이브 웹캐스트 접속
- 전화 참여 (사전 등록 필요)
- 회사 투자자 웹페이지에서 다시보기 제공
등록된 전화 참여자에게는 고유한 접속 코드와 등록자 ID가 포함된 다이얼인 정보가 담긴 확인 이메일이 발송됩니다.
Emergent BioSolutions (NYSE : EBS) a programmé sa conférence téléphonique sur les résultats financiers du premier trimestre 2025 pour le 7 mai 2025 à 17h00, heure de l'Est. La société offrira aux investisseurs et parties prenantes un accès à la conférence téléphonique via plusieurs canaux :
- Accès à la diffusion en direct
- Participation téléphonique (inscription préalable requise)
- Disponibilité du replay sur la page Investisseurs du site de l'entreprise
Les participants téléphoniques inscrits recevront un email de confirmation avec les détails de connexion, incluant un code d'accès unique et un identifiant d'inscription pour accéder à l'appel.
Emergent BioSolutions (NYSE: EBS) hat seine Telefonkonferenz zu den Finanzergebnissen des ersten Quartals 2025 für den 7. Mai 2025 um 17:00 Uhr Eastern Time angesetzt. Das Unternehmen bietet Investoren und Interessenten Zugang zur Telefonkonferenz über mehrere Kanäle:
- Live-Webcast-Zugang
- Telefonische Teilnahme (erfordert vorherige Anmeldung)
- Wiedergabe auf der Investorenseite des Unternehmens
Registrierte Telefonteilnehmer erhalten Bestätigungsmails mit Einwahldaten, einschließlich eines einzigartigen Zugangscodes und einer Registrierungs-ID für den Zugriff auf den Anruf.
- None.
- None.
GAITHERSBURG, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 7, 2025, at 5:00 pm eastern time to discuss the financial results for the first quarter of 2025.
Participants can access the conference call live via webcast, and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
FAQ
When will Emergent BioSolutions (EBS) release Q1 2025 earnings?
How can investors join the Emergent BioSolutions Q1 2025 earnings call?
Will there be a replay available for EBS Q1 2025 earnings call?
What information is needed to access EBS Q1 2025 earnings call by phone?
